UMGCC Appoints Dr. Clement Adebamowo as Associate Director of Population Science Program
For immediate release: August 03, 2015
The University of Maryland Marlene and Stewart Greenebaum Cancer Center (UMGCC) announced the appointment of Clement Adebamowo, MB ChB, FACS, ScD, as Associate Director for its Population Science research program effective August 1, 2015. Dr. Adebamowo succeeds Dr. William Blattner, MD, who is retiring later this year.
Dr. Adebamowo is a Member of the Institute of Human Virology and Professor in the Division of Cancer Epidemiology in the Department of Epidemiology and Public Health at the University of Maryland School of Medicine. His research centers on improving knowledge of the molecular biology of HPV associated cancer (cervical and head and neck cancers) and breast cancer. His research also includes identification of new genomics and epigenomics biomarkers of cervical cancer in West Africa. Results will provide insights into cancer incidence and inform treatment decisions on a global level.
In addition to his cancer-related research in West Africa, Dr. Adebamowo is also working to develop overall research infrastructure in Nigeria through establishment of a sustainable research ethics regulatory framework, training in good clinical practice and research misconduct, principles and practice of clinical trials, and building collaborative research groups. The Institute of Human Virology’s large HIV treatment and prevention program in Nigeria provides an opportunity explore the effects of oncoviruses in HIV-positive and -negative populations.
“As an internationally-recognized researcher in the field of global public health, Dr. Adebamowo is a major influencer in cancer research around the world as well as a prominent contributor to UMGCC’s Population Science portfolio,” states Kevin Cullen, MD, Cancer Center director and the Marlene and Stewart Greenebaum Distinguished Professor in Oncology at the University of Maryland School of Medicine.
In his new role, Dr. Adebamowo will work closely with program co-leaders Joanne Dorgan, PhD, Professor in the Department of Epidemiology and Public Health at the University of Maryland School of Medicine and Cheryl Holt, PhD, Associate Professor at the University of Maryland College Park’s School of Public Health, to expand overall population science efforts of the Cancer Center.
Established in 2013, the Population Science program conducts research to identify determinants of cancer etiology and survivorship, characterize cancer-related health behaviors, and translate basic discoveries into behavioral cancer prevention and control interventions. It is the newest of five focused sub-programs that comprise the Cancer Center’s multidisciplinary research program, which seeks to transfer knowledge from the laboratory to the clinic in an effort to understand mechanisms of disease and develop and apply innovative cancer treatment and prevention strategies to the Maryland community and beyond.
The Population Science program signifies the Cancer Center’s progression toward becoming a “comprehensive cancer center” as defined by the National Cancer Institute. This designation is the gold standard for multidisciplinary cancer research centers. To date, only 41 centers nationwide have achieved this status.
Already an NCI-designated cancer center, UMGCC is known nationwide for world-class laboratory and clinical research programs. The addition of the Population Science program in combination with community education and outreach efforts positions the center well for achieving this designation of excellence in 2016.
“While I want to express my sincere appreciation to Dr. Adebamowo for taking on these new responsibilities, I want to first thank Dr. Blattner for his vision and leadership over the last 10 years, which have resulted in a robust population science research program at UMGCC,” says Dr. Cullen. “This program is the centerpiece of our effort to achieve comprehensive cancer center designation. With Dr. Adebamowo's stature in the field of global health, I feel confident that our already outstanding group of investigators will continue to grow and make important public health contributions in the future.”
Dr. Adebamowo received his medical degree from the University of Jos in Nigeria and then went on to receive his surgical training at the University College Hospital in Ibadan, Nigeria. He subsequently received a Doctor of Science degree in epidemiology and nutrition from the Harvard School of Public Health. He serves as director of the Nigerian National System of Cancer Registries; Chairman of the National Health Research Ethics Committee of Nigeria; Director of the Center for Bioethics in Ibadan, Nigeria and Director of the West African Framework Program for Global Health.
Dr. Adebamowo is the principal investigator of the NIH-funded African Collaborative Center for Microbiome and Genomics Research, which is part of the NIH/Wellcome Trust–funded Human Heredity and Health in Africa initiative on genomics research and education in Africa. He is also principal investigator of the Fogarty-funded Training Program in Nigeria for NCD Research. Finally, he directs the Fogarty-funded West African Bioethics Training Program.